These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36288915)

  • 1. A retrospective comparative study of microwave ablation and sublobectomy in the treatment of early subpleural nonsmall cell lung cancer.
    Liu J; Wang C; Yi W; Zheng H; Zheng A
    Int J Hyperthermia; 2022; 39(1):1379-1386. PubMed ID: 36288915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of safety margin after microwave ablation of stage I NSCLC with three-dimensional reconstruction technique using CT imaging.
    Yan P; Tong AN; Nie XL; Ma MG
    BMC Med Imaging; 2021 Jun; 21(1):96. PubMed ID: 34098894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography-guided microwave ablation for the treatment of non-small cell lung cancer patients with and without adjacent lobe invasion: A comparative study.
    Xu S; Bie ZX; Li YM; Li B; Guo RQ; Li XG
    Thorac Cancer; 2021 Oct; 12(20):2780-2788. PubMed ID: 34427998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and feasibility of three-dimensional visualization planning system for CT-guided microwave ablation of stage I NSCLC (diameter ≤2.5 cm): A pilot study.
    Hu Y; Xue G; Liang X; Wu J; Zhang P; Wang N; Li Z; Cao P; Wang G; Cai H; Wei Z; Ye X
    J Cancer Res Ther; 2023 Feb; 19(1):64-70. PubMed ID: 37006044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated percutaneous microwave ablation for local recurrence of inoperable Stage I nonsmall cell lung cancer.
    Yang X; Ye X; Huang G; Han X; Wang J; Li W; Wei Z; Meng M
    J Cancer Res Ther; 2017; 13(4):683-688. PubMed ID: 28901314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment.
    Ni Y; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Wei Z; Meng M
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):197-203. PubMed ID: 31599340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave Ablation Versus Wedge Resection for Stage I Non-small Cell Lung Cancer Adjacent to the Pericardium: Propensity Score Analyses of Long-term Outcomes.
    Hu H; Zhai B; Liu R; Chi JC
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):237-246. PubMed ID: 32909064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis.
    Peng J; Bie Z; Li Y; Guo R; Li X
    Eur Radiol; 2024 Jul; 34(7):4708-4715. PubMed ID: 38114848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation.
    Aufranc V; Farouil G; Abdel-Rehim M; Smadja P; Tardieu M; Aptel S; Guibal A
    Diagn Interv Imaging; 2019 Dec; 100(12):781-791. PubMed ID: 31402333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study.
    Wu C; Cao B; He G; Li Y; Wang W
    BMC Cancer; 2024 Mar; 24(1):304. PubMed ID: 38448897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous lung microwave ablation versus lung resection in high-risk patients. A monocentric experience.
    Mendogni P; Daffrè E; Rosso L; Palleschi A; Righi I; Carrinola R; Damarco F; Polli F; Ierardi A; Arrichiello A; Carrafiello G; Nosotti M; Tosi D
    Acta Biomed; 2020 Sep; 91(10-S):e2020002. PubMed ID: 33245066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage treatment of NSCLC recurrence after first-line chemotherapy failure: Iodine-125 seed brachytherapy or microwave ablation?
    Liu B; Wang Y; Tian S; Hertzanu Y; Zhao X; Li Y
    Thorac Cancer; 2020 Mar; 11(3):697-703. PubMed ID: 31995853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases.
    Yang X; Ye X; Zheng A; Huang G; Ni X; Wang J; Han X; Li W; Wei Z
    J Surg Oncol; 2014 Nov; 110(6):758-63. PubMed ID: 24965604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave Ablation (MWA) of Pulmonary Neoplasms: Clinical Performance of High-Frequency MWA With Spatial Energy Control Versus Conventional Low-Frequency MWA.
    Vogl TJ; Basten LM; Nour-Eldin NA; Kaltenbach B; Ackermann H; Naguib NNN
    AJR Am J Roentgenol; 2019 Dec; 213(6):1388-1396. PubMed ID: 31593520
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non-small-cell lung cancer: A propensity-match analysis.
    Wald O; Sadeh BM; Bdolah-Abram T; Erez E; Shapira OM; Izhar U
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1339. PubMed ID: 33570255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study.
    Ni Y; Bi J; Ye X; Fan W; Yu G; Yang X; Huang G; Li W; Wang J; Han X; Ni X; Wei Z; Han M; Zheng A; Meng M; Xue G; Zhang L; Wan C
    Medicine (Baltimore); 2016 Jun; 95(25):e3998. PubMed ID: 27336903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results.
    Ni Y; Huang G; Yang X; Ye X; Li X; Feng Q; Li Y; Li W; Wang J; Han X; Meng M; Zou Z; Wei Z
    Eur Radiol; 2022 Aug; 32(8):5616-5622. PubMed ID: 35226157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of local control after percutaneous microwave ablation versus partial nephrectomy: A propensity score matched study.
    Panhelleux M; Balssa L; David A; Thiery-Vuillemin A; Kleinclauss F; Frontczak A
    Fr J Urol; 2024 Jan; 34(1):102534. PubMed ID: 37798161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.